Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Henry Schein : Announces $400 Million Increase to Share Repurchase Plan

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/31/2019 | 07:10am EST

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock.

This program is in addition to the $400 million repurchase program announced in December 2018, which as of today has approximately $75 million remaining authorized for future repurchases.

The Company had approximately 147 million shares outstanding as of October 30, 2019. This new authorization represents approximately 4.0 percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market, or through negotiated transactions.

"Henry Schein's share repurchase program demonstrates our long-term commitment to create additional shareholder value and reflects our confidence in the long-term prospects of our business," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "We are pleased that Henry Schein's solid balance sheet provides us with the financial flexibility to return capital to our shareholders, as we continue to pursue new markets and geographies while strengthening and broadening our health care product and service offerings."

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate," “to be,” “to make” or other comparable terms. A full discussion of our operations and financial condition, status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive and consolidating market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic conditions; risks associated with currency fluctuations; risks associated with political and economic uncertainty; disruptions in financial markets; volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; new or unanticipated litigation developments and the status of litigation matters; the dependence on our continued product development, technical support and successful marketing in the technology segment; our dependence on third parties for certain technologically advanced components; increased competition by third party online commerce sites; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HENRY SCHEIN, INC.
12/04HENRY SCHEIN : and the National Council on Disability Ally to Improve Access to ..
BU
12/03HENRY SCHEIN : Chairman and CEO Stanley M. Bergman Honored for Advancing Diversi..
BU
11/21SHAREHOLDER ALERT : Robbins LLP Announces Complaint Filed Against Henry Schein, ..
BU
11/21HENRY SCHEIN : to Present New Products and Solutions, Educational Offerings, and..
BU
11/20HENRY SCHEIN : to Present at Nasdaq's 41st Investor Conference
BU
11/05HENRY SCHEIN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
11/05HENRY SCHEIN : Vertical Market Data
PU
11/05HENRY SCHEIN : Reconciliation of GAAP and Non-GAAP Measures
PU
11/05HENRY SCHEIN : 3Q Earnings Snapshot
AQ
11/05HENRY SCHEIN INC : Results of Operations and Financial Condition, Financial Stat..
AQ
More news
Financials (USD)
Sales 2019 9 960 M
EBIT 2019 725 M
Net income 2019 500 M
Debt 2019 1 003 M
Yield 2019 -
P/E ratio 2019 20,6x
P/E ratio 2020 18,7x
EV / Sales2019 1,12x
EV / Sales2020 1,05x
Capitalization 10 150 M
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 67,50  $
Last Close Price 69,17  $
Spread / Highest target 15,7%
Spread / Average Target -2,41%
Spread / Lowest Target -19,0%
EPS Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.10.47%10 150
CANTEL MEDICAL CORP.4.46%3 322
SHIP HEALTHCARE HOLDINGS, INC.21.43%2 035
PATTERSON COMPANIES17.50%1 909
AS ONE CORPORATION29.63%1 647
MERIT MEDICAL SYSTEMS, INC.-49.01%1 568